valproic acid and tae226

valproic acid has been researched along with tae226 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abd El-Hafeez, AA; Abdelhamid, D; Abuo-Rahma, GEA; Ghosh, P; Hayallah, AM; Katkar, GD; Mostafa, YA; Mustafa, M	1

Other Studies

1 other study(ies) available for valproic acid and tae226

Article	Year
A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles. European journal of medicinal chemistry, 2021, Oct-15, Volume: 222 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Focal Adhesion Kinase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured	2021

Article

Year

A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.

European journal of medicinal chemistry, 2021, Oct-15, Volume: 222

Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Focal Adhesion Kinase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured

2021